Pancreatic Cancer Research

ResearcherUniversity of North Carolina at Chapel HillActive in the last 2 years

ALBERT Sidney BALDWIN

Matched on ORCID iD 0000-0003-1246-1333; OpenAlex author ID A5034236608; NIH RePORTER profile ID 1861018. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
1
Labs led
1
Collaborators
12
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 grant

Papers 3

  1. ERK signaling promotes IKKε expression and oncogenic functions in pancreatic cancer cells in association with TBK1. Last author DOI 10.1016/j.jbc.2025.110535↗
  2. GSK-3α promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-κB. Last author DOI 10.1158/2159-8290.cd-12-0541↗
  3. Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine. Co-author DOI 10.4161/cbt.24343↗

Grants 1

  1. SToP Cancer SPORE: Administrative Core A P50CA257911↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jen Jen Yeh · 1 shared paper, 1 shared grant, 2013–2026 · strength 0.71
  2. Alina Cornelia Iuga · 1 shared grant, 2026 · strength 0.67
  3. Michael R Kosorok · 1 shared grant, 2026 · strength 0.67
  4. Gianpietro Dotti · 1 shared grant, 2026 · strength 0.67
  5. Channing J. Der · 1 shared grant, 2026 · strength 0.67
  6. Jonathan S. Serody · 1 shared grant, 2026 · strength 0.67
  7. Adam C. Graves · 1 shared paper, 2025 · strength 0.27
  8. Kirsten L. Bryant · 1 shared paper, 2025 · strength 0.27
  9. Deepali Bang · 1 shared paper, 2013 · strength 0.05
  10. Meagan B. Ryan · 1 shared paper, 2013 · strength 0.05
  11. Dapeng Xu · 1 shared paper, 2013 · strength 0.03
  12. Antonio T. Baines · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.